236 related articles for article (PubMed ID: 35027755)
21. A Deep Learning Approach to Diagnostic Classification of Prostate Cancer Using Pathology-Radiology Fusion.
Khosravi P; Lysandrou M; Eljalby M; Li Q; Kazemi E; Zisimopoulos P; Sigaras A; Brendel M; Barnes J; Ricketts C; Meleshko D; Yat A; McClure TD; Robinson BD; Sboner A; Elemento O; Chughtai B; Hajirasouliha I
J Magn Reson Imaging; 2021 Aug; 54(2):462-471. PubMed ID: 33719168
[TBL] [Abstract][Full Text] [Related]
22. A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts.
Ankerst DP; Straubinger J; Selig K; Guerrios L; De Hoedt A; Hernandez J; Liss MA; Leach RJ; Freedland SJ; Kattan MW; Nam R; Haese A; Montorsi F; Boorjian SA; Cooperberg MR; Poyet C; Vertosick E; Vickers AJ
Eur Urol; 2018 Aug; 74(2):197-203. PubMed ID: 29778349
[TBL] [Abstract][Full Text] [Related]
23. Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate.
Dess RT; Suresh K; Zelefsky MJ; Freedland SJ; Mahal BA; Cooperberg MR; Davis BJ; Horwitz EM; Terris MK; Amling CL; Aronson WJ; Kane CJ; Jackson WC; Hearn JWD; Deville C; DeWeese TL; Greco S; McNutt TR; Song DY; Sun Y; Mehra R; Kaffenberger SD; Morgan TM; Nguyen PL; Feng FY; Sharma V; Tran PT; Stish BJ; Pisansky TM; Zaorsky NG; Moraes FY; Berlin A; Finelli A; Fossati N; Gandaglia G; Briganti A; Carroll PR; Karnes RJ; Kattan MW; Schipper MJ; Spratt DE
JAMA Oncol; 2020 Dec; 6(12):1912-1920. PubMed ID: 33090219
[TBL] [Abstract][Full Text] [Related]
24. Evaluating the Four Kallikrein Panel of the 4Kscore for Prediction of High-grade Prostate Cancer in Men in the Canary Prostate Active Surveillance Study.
Lin DW; Newcomb LF; Brown MD; Sjoberg DD; Dong Y; Brooks JD; Carroll PR; Cooperberg M; Dash A; Ellis WJ; Fabrizio M; Gleave ME; Morgan TM; Nelson PS; Thompson IM; Wagner AA; Zheng Y;
Eur Urol; 2017 Sep; 72(3):448-454. PubMed ID: 27889277
[TBL] [Abstract][Full Text] [Related]
25. Interobserver reproducibility of cribriform cancer in prostate needle biopsies and validation of International Society of Urological Pathology criteria.
Egevad L; Delahunt B; Iczkowski KA; van der Kwast T; van Leenders GJLH; Leite KRM; Pan CC; Samaratunga H; Tsuzuki T; Mulliqi N; Ji X; Olsson H; Valkonen M; Ruusuvuori P; Eklund M; Kartasalo K
Histopathology; 2023 May; 82(6):837-845. PubMed ID: 36645163
[TBL] [Abstract][Full Text] [Related]
26. Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens.
Sauter G; Steurer S; Clauditz TS; Krech T; Wittmer C; Lutz F; Lennartz M; Janssen T; Hakimi N; Simon R; von Petersdorff-Campen M; Jacobsen F; von Loga K; Wilczak W; Minner S; Tsourlakis MC; Chirico V; Haese A; Heinzer H; Beyer B; Graefen M; Michl U; Salomon G; Steuber T; Budäus LH; Hekeler E; Malsy-Mink J; Kutzera S; Fraune C; Göbel C; Huland H; Schlomm T
Eur Urol; 2016 Apr; 69(4):592-598. PubMed ID: 26542947
[TBL] [Abstract][Full Text] [Related]
27. A systematic review and meta-analysis of artificial intelligence diagnostic accuracy in prostate cancer histology identification and grading.
Morozov A; Taratkin M; Bazarkin A; Rivas JG; Puliatti S; Checcucci E; Belenchon IR; Kowalewski KF; Shpikina A; Singla N; Teoh JYC; Kozlov V; Rodler S; Piazza P; Fajkovic H; Yakimov M; Abreu AL; Cacciamani GE; Enikeev D;
Prostate Cancer Prostatic Dis; 2023 Dec; 26(4):681-692. PubMed ID: 37185992
[TBL] [Abstract][Full Text] [Related]
28. A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.
Klein EA; Cooperberg MR; Magi-Galluzzi C; Simko JP; Falzarano SM; Maddala T; Chan JM; Li J; Cowan JE; Tsiatis AC; Cherbavaz DB; Pelham RJ; Tenggara-Hunter I; Baehner FL; Knezevic D; Febbo PG; Shak S; Kattan MW; Lee M; Carroll PR
Eur Urol; 2014 Sep; 66(3):550-60. PubMed ID: 24836057
[TBL] [Abstract][Full Text] [Related]
29. Recent advances in prostate cancer pathology: Gleason grading and beyond.
Shah RB; Zhou M
Pathol Int; 2016 May; 66(5):260-72. PubMed ID: 26991008
[TBL] [Abstract][Full Text] [Related]
30. Interobserver variability in Gleason histological grading of prostate cancer.
Ozkan TA; Eruyar AT; Cebeci OO; Memik O; Ozcan L; Kuskonmaz I
Scand J Urol; 2016 Dec; 50(6):420-424. PubMed ID: 27416104
[TBL] [Abstract][Full Text] [Related]
31. Standardization of Gleason grading among 337 European pathologists.
Egevad L; Ahmad AS; Algaba F; Berney DM; Boccon-Gibod L; Compérat E; Evans AJ; Griffiths D; Grobholz R; Kristiansen G; Langner C; Lopez-Beltran A; Montironi R; Moss S; Oliveira P; Vainer B; Varma M; Camparo P
Histopathology; 2013 Jan; 62(2):247-56. PubMed ID: 23240715
[TBL] [Abstract][Full Text] [Related]
32. Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer.
Truong M; Slezak JA; Lin CP; Iremashvili V; Sado M; Razmaria AA; Leverson G; Soloway MS; Eggener SE; Abel EJ; Downs TM; Jarrard DF
Cancer; 2013 Nov; 119(22):3992-4002. PubMed ID: 24006289
[TBL] [Abstract][Full Text] [Related]
33. Critical evaluation of artificial intelligence as a digital twin of pathologists for prostate cancer pathology.
Eminaga O; Abbas M; Kunder C; Tolkach Y; Han R; Brooks JD; Nolley R; Semjonow A; Boegemann M; West R; Long J; Fan RE; Bettendorf O
Sci Rep; 2024 Mar; 14(1):5284. PubMed ID: 38438436
[TBL] [Abstract][Full Text] [Related]
34. A comparison of interobserver reproducibility of Gleason grading of prostatic carcinoma in Japan and the United States.
Oyama T; Allsbrook WC; Kurokawa K; Matsuda H; Segawa A; Sano T; Suzuki K; Epstein JI
Arch Pathol Lab Med; 2005 Aug; 129(8):1004-10. PubMed ID: 16048389
[TBL] [Abstract][Full Text] [Related]
35. WeGleNet: A weakly-supervised convolutional neural network for the semantic segmentation of Gleason grades in prostate histology images.
Silva-Rodríguez J; Colomer A; Naranjo V
Comput Med Imaging Graph; 2021 Mar; 88():101846. PubMed ID: 33485056
[TBL] [Abstract][Full Text] [Related]
36. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.
Epstein JI; Egevad L; Amin MB; Delahunt B; Srigley JR; Humphrey PA;
Am J Surg Pathol; 2016 Feb; 40(2):244-52. PubMed ID: 26492179
[TBL] [Abstract][Full Text] [Related]
37. Gleason grading of prostate cancer in needle core biopsies: a comparison of general and urologic pathologists.
Al-Maghrabi JA; Bakshi NA; Farsi HM
Ann Saudi Med; 2013; 33(1):40-4. PubMed ID: 23458939
[TBL] [Abstract][Full Text] [Related]
38. Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study.
Brown LC; Ahmed HU; Faria R; El-Shater Bosaily A; Gabe R; Kaplan RS; Parmar M; Collaco-Moraes Y; Ward K; Hindley RG; Freeman A; Kirkham A; Oldroyd R; Parker C; Bott S; Burns-Cox N; Dudderidge T; Ghei M; Henderson A; Persad R; Rosario DJ; Shergill I; Winkler M; Soares M; Spackman E; Sculpher M; Emberton M
Health Technol Assess; 2018 Jul; 22(39):1-176. PubMed ID: 30040065
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Classic and International Society of Urological Pathology 2005 Modified Gleason grading using needle biopsies from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial.
Lucia MS; Bostwick DG; Somerville MC; Fowler IL; Rittmaster RS
Arch Pathol Lab Med; 2013 Dec; 137(12):1740-6. PubMed ID: 24283854
[TBL] [Abstract][Full Text] [Related]
40. Frequency and determinants of disagreement and error in gleason scores: a population-based study of prostate cancer.
Goodman M; Ward KC; Osunkoya AO; Datta MW; Luthringer D; Young AN; Marks K; Cohen V; Kennedy JC; Haber MJ; Amin MB
Prostate; 2012 Sep; 72(13):1389-98. PubMed ID: 22228120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
